{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:34:14Z","timestamp":1771295654852,"version":"3.50.1"},"reference-count":199,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006742","name":"Cooperativa de Ensino Superior Polit\u00e9cnico e Universit\u00e1rio","doi-asserted-by":"publisher","award":["CHIRALBIOACTIVE-PI-3RL-IINFACTS-2019"],"award-info":[{"award-number":["CHIRALBIOACTIVE-PI-3RL-IINFACTS-2019"]}],"id":[{"id":"10.13039\/501100006742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006742","name":"Cooperativa de Ensino Superior Polit\u00e9cnico e Universit\u00e1rio","doi-asserted-by":"publisher","award":["CHIRALSINTESE-APSFCT-IINFACTS_2021"],"award-info":[{"award-number":["CHIRALSINTESE-APSFCT-IINFACTS_2021"]}],"id":[{"id":"10.13039\/501100006742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04423\/2020 and UIDP\/04423\/2020"],"award-info":[{"award-number":["UIDB\/04423\/2020 and UIDP\/04423\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-028736"],"award-info":[{"award-number":["POCI-01-0145-FEDER-028736"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chemosensors"],"abstract":"<jats:p>The interaction between proteins and drugs or other bioactive compounds has been widely explored over the past years. Several methods for analysis of this phenomenon have been developed and improved. Nowadays, increasing attention is paid to innovative methods, such as high performance affinity liquid chromatography (HPALC) and affinity capillary electrophoresis (ACE), taking into account various advantages. Moreover, the development of separation methods for the analysis and resolution of chiral drugs has been an area of ongoing interest in analytical and medicinal chemistry research. In addition to bioaffinity binding studies, both HPALC and ACE al-low one to perform other type of analyses, namely, displacement studies and enantioseparation of racemic or enantiomeric mixtures. Actually, proteins used as chiral selectors in chromatographic and electrophoretic methods have unique enantioselective properties demonstrating suitability for the enantioseparation of a large variety of chiral drugs or other bioactive compounds. This review is mainly focused in chromatographic and electrophoretic methods using human serum albumin (HSA), the most abundant plasma protein, as chiral selector for binding affinity analysis and enantioresolution of drugs. For both analytical purposes, updated examples are presented to highlight recent applications and current trends.<\/jats:p>","DOI":"10.3390\/chemosensors9110304","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T21:40:21Z","timestamp":1635198021000},"page":"304","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Enantioresolution and Binding Affinity Studies on Human Serum Albumin: Recent Applications and Trends"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5683-2776","authenticated-orcid":false,"given":"Tony","family":"Cardoso","sequence":"first","affiliation":[{"name":"Laborat\u00f3rio de Qu\u00edmica Org\u00e2nica e Farmac\u00eautica, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6826-1854","authenticated-orcid":false,"given":"Ana Sofia","family":"Almeida","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Qu\u00edmica Org\u00e2nica e Farmac\u00eautica, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-5119","authenticated-orcid":false,"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[{"name":"UCIBIO-REQUIMTE Laborat\u00f3rio de Toxicologia, Departamento de Ci\u00eancias Biol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-9163","authenticated-orcid":false,"given":"Carla","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Qu\u00edmica Org\u00e2nica e Farmac\u00eautica, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"},{"name":"Centro Interdisciplinar de Investiga\u00e7\u00e3o Marinha e Ambiental (CIIMAR), Universidade do Porto, Terminal de Cruzeiros do Porto de Leix\u00f5es, Avenida General Norton de Matos, s\/n, 4450-208 Matosinhos, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jssc.200800640","article-title":"Characterization of drug-protein interactions in blood using high-performance affinity chromatography","volume":"32","author":"Hage","year":"2009","journal-title":"J. Sep. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jpba.2017.01.026","article-title":"Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective","volume":"144","author":"Li","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.drudis.2011.12.018","article-title":"Compilation of 222 drugs\u2019 plasma protein binding data and guidance for study designs","volume":"17","author":"Zhang","year":"2012","journal-title":"Drug Discov. Today"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11095-018-2551-x","article-title":"Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein","volume":"36","author":"Smith","year":"2018","journal-title":"Pharm. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41598-017-00685-9","article-title":"VLDL\/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body","volume":"7","author":"Yamamoto","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_6","first-page":"1","article-title":"Role of protein binding in pharmacokinetics","volume":"5","author":"Mehvar","year":"2005","journal-title":"Am. J. Pharm. Educ."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/jps.23614","article-title":"Plasma protein binding: From discovery to development","volume":"102","author":"Bohnert","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Yerena, A., Perez, M., Vallverd\u00fa-Queralt, A., and Escribano-Ferrer, E. (2020). Insights into the binding of dietary phenolic compounds to human serum albumin and food-drug interactions. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12111123"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jpba.2004.10.050","article-title":"In vitro plasma protein binding determination of flunarizine using equilibrium dialysis and liquid chromatography-tandem mass spectrometry","volume":"37","author":"Lin","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-012-0018-5","article-title":"The clinical relevance of plasma protein binding changes","volume":"52","author":"Roberts","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"ref_11","unstructured":"Donev, R. (2016). High-Performance Affinity Chromatography: Applications in Drug-Protein Binding Studies and Personalized Medicine. Personalized Medicine, Academic Press Inc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.2174\/0929867323666160425113058","article-title":"Drug-like properties and ADME of xanthone derivatives: The antechamber of clinical trials","volume":"23","author":"Gomes","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Di, L. (2021). An update on the importance of plasma protein binding in drug discovery and development. Expert Opin. Drug Discov., 1\u201313.","DOI":"10.1080\/17460441.2021.1961741"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1067\/mcp.2002.121829","article-title":"Changes in plasma protein binding have little clinical relevance","volume":"71","author":"Benet","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/jps.21916","article-title":"Significance of protein binding in pharmacokinetics and pharmacodynamics","volume":"99","author":"Schmidt","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2125.1994.tb04251.x","article-title":"Plasma protein binding displacement interactions\u2014Why are they still regarded as clinically important?","volume":"37","author":"Rolan","year":"1994","journal-title":"Br. J. Clin. Pharmac."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1002\/jps.20733","article-title":"Prediction of plasma protein binding displacement and its implications for quantitative assessment of metabolic drug-drug interactions from in vitro data","volume":"95","author":"Christensen","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2165\/00003495-198325050-00003","article-title":"Protein binding displacement interactions and their clinical importance","volume":"25","author":"McElnay","year":"1983","journal-title":"Drugs"},{"key":"ref_20","first-page":"691","article-title":"Comparative interaction of sulfinpyrazone and phenylbutazone with racemic warfarin: Alteration in vivo of free fraction of plasma warfarin","volume":"219","author":"Goulart","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/clpt.1980.235","article-title":"Interaction between phenytoin and valproic acid: Plasma protein binding and metabolic effects","volume":"28","author":"Perucca","year":"1980","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_22","first-page":"10","article-title":"Exploiting the power of stereochemistry in drugs: An overview of racemic and enantiopure drugs","volume":"1","author":"Sekhon","year":"2013","journal-title":"J. Mod. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jat\/bkx074","article-title":"Chiral Resolution and Enantioselectivity of Synthetic Cathinones: A Brief Review","volume":"42","author":"Silva","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfp097","article-title":"Chiral toxicology: It\u2019s the same thing only different","volume":"110","author":"Smith","year":"2009","journal-title":"Toxicol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Coelho, M.M., Fernandes, C., Remi\u00e3o, F., and Tiritan, M.E. (2021). Enantioselectivity in drug pharmacokinetics and toxicity: Pharmacological relevance and analytical methods. Molecules, 26.","DOI":"10.3390\/molecules26113113"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Fernandes, C., Carraro, M.L., Ribeiro, J., Ara\u00fajo, J., Tiritan, M.E., and Pinto, M.M.M. (2019). Synthetic chiral derivatives of xanthones: Biological activities and enantioselectivity studies. Molecules, 24.","DOI":"10.3390\/molecules24040791"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1021\/ed084p2012","article-title":"Unequal activities of enantiomers via biological receptors: Examples of chiral drug, pesticide, and fragrance molecules","volume":"84","author":"Mannschreck","year":"2007","journal-title":"J. Chem. Ed."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Tiritan, M.E., Ribeiro, A.R., Fernandes, C., and Pinto, M. (2016). Chiral Pharmaceuticals. Kirk-Othmer Encyclopedia of Chemicl Technology, John Wiley & Sons, Inc.","DOI":"10.1002\/0471238961.1608011823092009.a01.pub2"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/aps.2013.78","article-title":"Stereoselective binding of chiral drugs to plasma proteins","volume":"34","author":"Shen","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/chir.20237","article-title":"Stereoselective binding of human serum albumin","volume":"18","author":"Chuangl","year":"2006","journal-title":"Chirality"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/chir.23162","article-title":"Structural investigations of stereoselective profen binding by equine and leporine serum albumins","volume":"32","author":"Zielinski","year":"2020","journal-title":"Chirality"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"117452","DOI":"10.1016\/j.saa.2019.117452","article-title":"Study on the stereoselective binding of cytosine nucleoside enantiomers to human serum albumin","volume":"224","author":"Liu","year":"2020","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.foodchem.2018.07.135","article-title":"Stereoselective interactions of lactic acid enantiomers with HSA: Spectroscopy and docking application","volume":"270","author":"Mu","year":"2019","journal-title":"Food Chem."},{"key":"ref_34","first-page":"3839","article-title":"Study of Stereoselective Interaction Between Ginsenoside Rh2 and Serum Albumin by Spectroscopic Methods and Molecular Docking","volume":"38","author":"Li","year":"2018","journal-title":"Spectrosc. Spectr. Anal."},{"key":"ref_35","first-page":"e90","article-title":"Assessing the chiral switch: Approval and use of single-enantiomer drugs, 2001 to 2011","volume":"20","author":"Gellad","year":"2014","journal-title":"Am. J. Manag. Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jpba.2017.07.008","article-title":"The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds","volume":"147","author":"Calcaterra","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_37","unstructured":"FDA (1992). FDA\u2019s policy statement for the development of new stereoisomeric drugs. 57 Fed. Reg., 22, 249."},{"key":"ref_38","unstructured":"(2021, September 14). Investigation of Chiral Active Substances. Directive 75\/318\/EEC. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/investigation-chiral-active-substances_en.pdf."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1039\/c2ob25184a","article-title":"Strategies for the enantioselective synthesis of spirooxindoles","volume":"10","author":"Badillo","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1039\/C5CS00622H","article-title":"Enantioselective syntheses of indanes: From organocatalysis to C-H functionalization","volume":"45","author":"Borie","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nature14007","article-title":"Catalytic enantioselective synthesis of quaternary carbon stereocentres","volume":"516","author":"Quasdorf","year":"2014","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1002\/ejoc.201000462","article-title":"Recent Progress in the Chemically Catalyzed Enantioselective Synthesis of Cyanohydrins","volume":"2010","author":"Wang","year":"2010","journal-title":"Euro. J. Org. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jchromb.2014.02.049","article-title":"Enantioseparation of chiral pharmaceuticals in biomedical and environmental analyses by liquid chromatography: An overview","volume":"968","author":"Ribeiro","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Pinto, M.M.M., Fernandes, C., and Tiritan, M.E. (2020). Chiral separations in preparative scale: A medicinal chemistry point of view. Molecules, 25.","DOI":"10.3390\/molecules25081931"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Fernandes, C., Tiritan, M.E., and Pinto, M.M.M. (2017). Chiral separation in preparative scale: A brief overview of membranes as tools for enantiomeric separation. Symmetry, 9.","DOI":"10.3390\/sym9100206"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.drudis.2010.01.007","article-title":"The strategy of enantiomer patents of drugs","volume":"15","author":"Agranat","year":"2010","journal-title":"Drug Discov. Today"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrd915","article-title":"Putting chirality to work: The strategy of chiral switches","volume":"1","author":"Agranat","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1359-6446(03)02904-0","article-title":"Trends in the development of chiral drugs","volume":"9","author":"Caner","year":"2004","journal-title":"Drug Discov. Today"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/bdd.517","article-title":"Drug disposition in three dimensions: An update on stereoselectivity in pharmacokinetics","volume":"27","author":"Brocks","year":"2006","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","article-title":"Predicting plasma protein binding of drugs: A new approach","volume":"64","author":"Kratochwil","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-4838(00)00153-9","article-title":"Alpha-1-acid glycoprotein","volume":"1482","author":"Fournier","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0065-3233(08)60640-3","article-title":"Structure of serum albumin","volume":"45","author":"Carter","year":"1994","journal-title":"Adv. Protein Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2015.03.011","article-title":"In Vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review","volume":"86","author":"Lambrinidis","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Bi, C., Zheng, X., Azaria, S., Beeram, S., Li, Z., and Hage, D.S. (2016). Chromatographic studies of protein-based chiral separations. Separations, 3.","DOI":"10.3390\/separations3030027"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.chroma.2018.11.021","article-title":"Designed affinity ligands to capture human serum albumin","volume":"1583","author":"Figueiredo","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"More, J., and Bulmer, M. (2013). Human serum albumin: A multifunctional plasma protein. Production of Plasma Proteins for Therapeutic Use.","DOI":"10.1002\/9781118356807.ch12"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/138955706776361448","article-title":"Allosteric modulation of drug binding to human serum albumin","volume":"6","author":"Ascenzi","year":"2006","journal-title":"Mini-Rev. Med. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1388-1981(99)00148-1","article-title":"Fatty acid binding to human serum albumin: New insights from crystallographic studies","volume":"1441","author":"Curry","year":"1999","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2036.16.s5.2.x","article-title":"Review article: Albumin as a drug\u2014Biological effects of albumin unrelated to oncotic pressure","volume":"16","author":"Evans","year":"2002","journal-title":"Aliment Pharmacol. Ther. Suppl."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature","volume":"9","author":"Gupta","year":"2010","journal-title":"Nutr. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1515\/CCLM.2011.037","article-title":"Ischemia modified albumin changes\u2014Review and clinical implications","volume":"49","author":"Sbarouni","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1507\/endocrj.K10E-138","article-title":"Clinical impact of glycated albumin as another glycemic control marker","volume":"57","author":"Koga","year":"2010","journal-title":"Endocr. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1039\/C9MD00018F","article-title":"Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics","volume":"10","author":"Zorzi","year":"2019","journal-title":"Med. Chem. Comm."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: From bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol. Aspects Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2011.09.069","article-title":"Impact of albumin on drug delivery--new applications on the horizon","volume":"157","author":"Elsadek","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.2174\/1381612824666180808145320","article-title":"Aspects of drug-protein binding and methods of analyzing the phenomenon","volume":"24","author":"Wanat","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00216-010-3737-1","article-title":"Drug-protein binding: A critical review of analytical tools","volume":"398","author":"Vuignier","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/138620710790596745","article-title":"Plasma protein binding in drug discovery and development","volume":"13","author":"Howard","year":"2010","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpba.2012.01.004","article-title":"Pharmaceutical and biomedical applications of affinity chromatography: Recent trends and developments","volume":"69","author":"Hage","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"116200","DOI":"10.1016\/j.molliq.2021.116200","article-title":"Studying the interaction of drug\/ligand with serum albumin","volume":"336","author":"Siddiqui","year":"2021","journal-title":"J. Mol. Liq."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jchromb.2004.06.006","article-title":"Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry","volume":"809","author":"Cheng","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jps.10332","article-title":"Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding","volume":"92","author":"Banker","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.chroma.2005.10.030","article-title":"High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry","volume":"1102","author":"Wan","year":"2006","journal-title":"J. Chromatogr. A."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jchromb.2006.02.053","article-title":"Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration","volume":"834","author":"Singh","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpba.2012.10.030","article-title":"High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions","volume":"74","author":"Vuignier","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9673(04)01338-X","article-title":"Development and evaluation of N-hydroxysuccinimide-activated silica for immobilizing human serum albumin in liquid chromatography columns","volume":"1049","author":"Kim","year":"2004","journal-title":"J. Chromatogr. A."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jchromb.2008.05.029","article-title":"Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC)","volume":"870","author":"Kim","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/ac00093a043","article-title":"Thermodynamic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin. Chiral separation mechanisms in protein-based HPLC columns. 661994","volume":"66","author":"Loun","year":"1994","journal-title":"Anal. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/ac00093a043","article-title":"Kinetic studies of (R)- and (S)-warfarin binding to immoblized human serum albumin. Chiral separation mechanisms in protein-based HPLC columns. 681996","volume":"66","author":"Loun","year":"1994","journal-title":"Anal. Chem."},{"key":"ref_82","unstructured":"Patel, S., Wainer, I.W., and Lough, W. (2006). Affinity based chiral stationary phases. Handbook of Affinity Chromatography, CRC."},{"key":"ref_83","first-page":"257","article-title":"Comparison of drug binding interactions on human, rat and rabbit serum albumin using high-performance displacement chromatography","volume":"112","author":"Aubry","year":"1995","journal-title":"Comp. Biochem. Physiol. Part C Pharmacol. Toxicol. Endocrinol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3109\/10837450.2016.1163392","article-title":"The effects of pH, temperature and protein concentration on the in vitro binding of flutamide to human serum albumin","volume":"22","author":"Esmaeilzadeh","year":"2017","journal-title":"Pharm. Dev. Technol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0021-9673(95)00339-O","article-title":"Quantitative structure-retention relationships of acyclovir esters using immobilised albumin high-performance liquid chromatography and reversed-phase high-performance liquid chromatography","volume":"707","author":"Ashton","year":"1995","journal-title":"J. Chromatogr. A"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.chroma.2009.10.022","article-title":"Chiral recognition by enantioselective liquid chromatography: Mechanisms and modern chiral stationary phases","volume":"1217","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10337-012-2261-1","article-title":"Chiral recognition mechanisms in analytical separation sciences","volume":"75","author":"Scriba","year":"2012","journal-title":"Chromatographia"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9673(00)00504-5","article-title":"Protein-based chiral stationary phases for high-performance liquid chromatography enantioseparations","volume":"906","author":"Haginaka","year":"2001","journal-title":"J. Chromatogr. A"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1073\/pnas.70.10.2850","article-title":"Resolution of DL-tryptophan by affinity chromatography on bovine serum albumin agarose columns","volume":"70","author":"Stewart","year":"1973","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0021-9673(01)95006-X","article-title":"Direct liquid chromatographic separation of enantiomers on immobilized protein stationary phases. III. Optical resolution of a series of N-aroyl d,l-amino acids by high-performance liquid chromatography on bovine serum albumin covalently bound to silica","volume":"264","author":"Allenmark","year":"1983","journal-title":"J. Chromatogr. A"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.aca.2011.08.038","article-title":"Recent applications in chiral high performance liquid chromatography: A review","volume":"706","author":"Cavazzini","year":"2011","journal-title":"Anal. Chim. Acta"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jchromb.2008.05.022","article-title":"Recent progresses in protein-based chiral stationary phases for enantioseparations in liquid chromatography","volume":"875","author":"Haginaka","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Teixeira, J., Tiritan, M.E., Pinto, M.M.M., and Fernandes, C. (2019). Chiral stationary phases for liquid chromatography: Recent developments. Molecules, 24.","DOI":"10.3390\/molecules24050865"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchromb.2003.08.035","article-title":"Separation of drug enantiomers by liquid chromatography and capillary electrophoresis, using immobilized proteins as chiral selectors","volume":"797","author":"Millot","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jssc.201500825","article-title":"Amino acids, peptides, and proteins as chemically bonded stationary phases\u2014A review","volume":"39","author":"Bocian","year":"2016","journal-title":"J. Sep. Sci."},{"key":"ref_96","unstructured":"Anderson, J., Berthod, A., Pino, V., and Stalcup, A.M. (2016). Analytical Separation Science, Wiley."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-4347(00)00424-2","article-title":"Structural changes of human serum albumin immobilized on chromatographic supports: A high-performance liquid chromatography and Fourier-transform infrared spectroscopy study","volume":"753","author":"Millot","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4155\/bio-2019-0074","article-title":"Enantioseparation, recognition mechanisms and binding of xanthones on human serum albumin by liquid chromatography","volume":"11","author":"Phyo","year":"2019","journal-title":"Bioanalysis"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2017.10.022","article-title":"Structural properties governing drug-plasma protein binding determined by high-performance liquid chromatography method","volume":"149","author":"Kamble","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-4347(01)00482-0","article-title":"High-performance affinity chromatography: A powerful tool for studying serum protein binding","volume":"768","author":"Hage","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0731-7085(98)00201-5","article-title":"High-performance frontal analysis for drug-protein binding study","volume":"18","author":"Shibukawa","year":"1999","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2174\/0929867023369673","article-title":"Reversible and Covalent Binding of Drugs to Human Serum Albumin: Methodological Approaches and Physiological Relevance","volume":"9","author":"Bertucci","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"ref_103","unstructured":"Cass, Q.B., and Degani, A.L.G. (2001). Desenvolvimento de M\u00e9todos por HPLC: Fundamentos, Estrat\u00e9gias e Valida\u00e7\u00e3o, Editora da UFCar."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/ac010643c","article-title":"Determination of Drug-plasma Protein Binding Kinetics and Equilibria by Chromatographic Profiling: Exemplification of the Method Using L-Tryptophan and Albumin","volume":"74","author":"Talbert","year":"2002","journal-title":"Anal. Chem."},{"key":"ref_105","first-page":"506","article-title":"Stereochemical aspects of benzodiazepine binding to human serum albumin. I. Enantioselective high performance liquid affinity chromatographic examination of chiral and achiral binding interactions between 1,4- benzodiazepines and human serum albumin","volume":"42","author":"Noctor","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"ref_106","first-page":"512","article-title":"Stereochemical aspects of benzodiazepine binding to human serum albumin. II. Quantitative relationships between structure and enantioselective retention in high performance liquid affinity chromatography","volume":"42","author":"Kaliszan","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0021-9673(94)01009-4","article-title":"Characterization of the protein binding of chiral drugs by high-performance affinity chromatography interactions of R- and S-ibuprofen with human serum albumin","volume":"693","author":"Hage","year":"1995","journal-title":"J. Chromatogr. A"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0021-9673(93)83383-4","article-title":"Characterization of the binding and chiral separation of d- and l-tryptophan on a high-performance immobilized human serum albumin column","volume":"645","author":"Yang","year":"1993","journal-title":"J. Chromatogr. A"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0378-4347(92)80386-5","article-title":"Characterization of thyroxine-albumin binding using high-performance affinity chromatography. I. Interactions at the warfarin and indole sites of albumin","volume":"579","author":"Loun","year":"1992","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0378-4347(94)00547-I","article-title":"Characterization of thyroxine-albumin binding using high-performance affinity chromatography II. Comparison of the binding of thyroxine, triiodothyronines and related compounds at the warfarin and indole sites of human serum albumin","volume":"665","author":"Loun","year":"1995","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchromb.2014.01.007","article-title":"Species-dependent binding of tocainide analogues to albumin: Affinity chromatography and circular dichroism study","volume":"968","author":"Pistolozzi","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jchromb.2009.02.070","article-title":"Studies of imipramine binding to human serum albumin by high-performance affinity chromatography","volume":"877","author":"Yoo","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.chroma.2015.09.023","article-title":"Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin","volume":"1416","author":"Matsuda","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1007\/s00216-015-8688-0","article-title":"Analysis of glipizide binding to normal and glycated human serum albumin by high-performance affinity chromatography","volume":"407","author":"Matsuda","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpba.2019.01.025","article-title":"Characterization of tolazamide binding with glycated and normal human serum albumin by using high-performance affinity chromatography","volume":"166","author":"Tao","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jchromb.2004.06.012","article-title":"Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography","volume":"809","author":"Chen","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/jssc.200900051","article-title":"HSA binding of HIV protease inhibitors: A high-performance affinity chromatography study","volume":"32","author":"Bertucci","year":"2009","journal-title":"J. Sep. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0928-0987(01)00219-6","article-title":"Evaluation of the human serum albumin column as a discovery screening tool for plasma protein binding","volume":"15","author":"Buchholz","year":"2002","journal-title":"Euro. J. Pharm. Sci."},{"key":"ref_119","first-page":"2236","article-title":"Fast Gradient HPLC Method to Determine Compounds Binding to Human Serum Albumin. Relationships with Octanol\/Water and Immobilized Artificial Membrane Lipophilicity","volume":"877","author":"Valko","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1016\/j.chroma.2011.08.026","article-title":"Characterization of interaction kinetics between chiral solutes and human serum albumin by using high-performance affinity chromatography and peak profiling","volume":"1218","author":"Tong","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.foodchem.2018.07.111","article-title":"Plasma protein binding of dietary polyphenols to human serum albumin: A high performance affinity chromatography approach","volume":"270","author":"Cao","year":"2019","journal-title":"Food Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jpba.2005.12.002","article-title":"Binding studies of taxanes to human serum albumin by bioaffinity chromatography and circular dichroism","volume":"42","author":"Bertucci","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jpba.2010.03.005","article-title":"Tocainide analogues binding to human serum albumin: A HPLAC and circular dichroism study","volume":"53","author":"Pistolozzi","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/10826076.2020.1811727","article-title":"An organic monolithic capillary column functionalized with human serum albumin and its application for the nano\u2014Chromatography study of its binding with universal cancer peptides and its impact on immunogenicity","volume":"43","author":"Claire","year":"2020","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"121812","DOI":"10.1016\/j.jchromb.2019.121812","article-title":"Development of an on-line immunoextraction\/entrapment system for protein capture and use in drug binding studies by high-performance affinity chromatography","volume":"1136","author":"Rodriguez","year":"2020","journal-title":"J. Chromatogr. B"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"114097","DOI":"10.1016\/j.jpba.2021.114097","article-title":"High-Performance affinity chromatographic studies of repaglinide and nateglinide interactions with normal and glyoxal- or methylglyoxal-modified human albumin serum","volume":"201","author":"Ovbude","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"114135","DOI":"10.1016\/j.jpba.2021.114135","article-title":"Studies of binding by 2-imidazolines to human serum albumin and alpha1-acid glycoprotein by high-performance affinity chromatography","volume":"202","author":"Woolfork","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Fernandes, C., Teixeira, J., Pinto, M.M.M., and Tiritan, M.E. (2021). Strategies for Preparation of Chiral Stationary Phases: Progress on Coating and Immobilization Methods. Molecules, 26.","DOI":"10.3390\/molecules26185477"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Matsuda, R., Anguizola, J., Hoy, K.S., and Hage, D.S. (2015). Analysis of drug\u2013protein interactions by high-performance affinity chromatography: Interactions of sulfonylurea drugs with normal and glycated human serum albumin. Methods in Molecular Biology, Humana Press Inc.","DOI":"10.1007\/978-1-4939-2447-9_21"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1021\/ac303734c","article-title":"Development of affinity microcolumns for drug-protein binding studies in personalized medicine: Interactions of sulfonylurea drugs with in vivo glycated human serum albumin","volume":"85","author":"Anguizola","year":"2013","journal-title":"Anal. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jchromb.2014.01.026","article-title":"Analysis of biomolecular interactions using affinity microcolumns: A review","volume":"968","author":"Zheng","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"ref_132","unstructured":"Daicel-Corporation (2021, September 14). INSTRUCTION MANUAL FOR CHIRALPAK\u00ae HAS. Available online: http:\/\/chiraltech.com\/wp-content\/uploads\/2018\/09\/CHIRALPAK-HSA-2018.pdf."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/0929867324666161118115711","article-title":"Human serum albumin as chiral selector in enantioselective high-performance liquid chromatography","volume":"24","author":"Bertucci","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1021\/ac1008496","article-title":"Investigations on the Coupling of High-Performance Liquid Chromatography to Direct Analysis in Real Time Mass Spectrometry","volume":"82","author":"Eberherr","year":"2010","journal-title":"Anal. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1021\/ac049001q","article-title":"High-performance affinity monolith chromatography: Development and evaluation of human serum albumin columns","volume":"76","author":"Mallik","year":"2005","journal-title":"Anal. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1515\/dmdi.2011.004","article-title":"Stereoselective binding of chiral anti-diabetic drug nateglinide to plasma proteins","volume":"26","author":"Maddi","year":"2011","journal-title":"Drug Metabol. Drug Interact."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0021-9673(99)01168-1","article-title":"Enantiomer separation of drugs by capillary electrophoresis using proteins as chiral selectors","volume":"875","author":"Haginaka","year":"2000","journal-title":"J. Chromatogr. A"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Hancu, G., Orlandini, S., Papp, L.A., Modroiu, A., Gotti, R., and Furlanetto, S. (2021). Application of Experimental Design Methodologies in the Enantioseparation of Pharmaceuticals by Capillary Electrophoresis: A Review. Molecules, 26.","DOI":"10.3390\/molecules26154681"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4155\/bio.14.261","article-title":"Recent advances in affinity capillary electrophoresis for binding studies","volume":"6","author":"Albishri","year":"2014","journal-title":"Bioanalysis"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/jm00093a027","article-title":"Use of affinity capillary electrophoresis to measure binding constants of ligands to proteins","volume":"35","author":"Chu","year":"1992","journal-title":"J. Med. Chem."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymeth.2018.05.006","article-title":"Affinity capillary electrophoresis for studying interactions in life sciences","volume":"146","author":"Olabi","year":"2018","journal-title":"Methods"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpba.2009.12.022","article-title":"Precision in affinity capillary electrophoresis for drug-protein binding studies","volume":"52","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/(SICI)1522-2683(19990701)20:9<1869::AID-ELPS1869>3.0.CO;2-3","article-title":"Study of enantioselective interactions between chiral drugs and serum albumin by capillary electrophoresis","volume":"20","author":"Zhu","year":"1999","journal-title":"Electrophoresis"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/ac00089a019","article-title":"Chiral separations in capillary electrophoresis using human serum albumin as a buffer additive","volume":"66","author":"Yang","year":"1994","journal-title":"Anal. Chem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/(SICI)1522-2683(19990701)20:9<1890::AID-ELPS1890>3.0.CO;2-E","article-title":"Study of interaction between drug enantiomers and serum albumin by capillary electrophoresis","volume":"20","author":"Ding","year":"1999","journal-title":"Electrophoresis"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF02467568","article-title":"Capillary electrophoresis study of human serum albumin binding to basic drugs","volume":"49","author":"Ding","year":"1999","journal-title":"Chromatographia"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0731-7085(02)00223-6","article-title":"Determination of protein-drug binding constants by pressure-assisted capillary electrophoresis (PACE)\/frontal analysis (FA)","volume":"30","author":"Jia","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/1522-2683(200203)23:6<956::AID-ELPS956>3.0.CO;2-7","article-title":"Identification of drug-binding sites on human serum albumin using affinity capillary electrophoresis and chemically modified proteins as buffer additives","volume":"23","author":"Kim","year":"2002","journal-title":"Electrophoresis"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Scriba, G.K.E., Harnisch, H., and Zhu, Q. (2016). Enantiomer separations by capillary electrophoresis. Methods in Molecular Biology, Humana Press Inc.","DOI":"10.1007\/978-1-4939-6403-1_15"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2116\/analsci.20.1409","article-title":"Enantiomeric separation of basic drugs with partially filled serum albumin as chiral selector in capillary electrophoresis","volume":"20","author":"Xu","year":"2004","journal-title":"Anal. Sci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/elps.200700748","article-title":"Study of interaction between drug enantiomers and human serum albumin by flow injection-capillary electrophoresis frontal analysis","volume":"29","author":"Liu","year":"2008","journal-title":"Electrophoresis"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/jssc.200800190","article-title":"Enantioseparation of nuarimol by affinity electrokinetic chromatography-partial filling technique using human serum albumin as chiral selector","volume":"31","author":"Sagrado","year":"2008","journal-title":"J. Sep. Sci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/bmc.3472","article-title":"Evaluation of the enantioselective binding of imazalil to human serum albumin by capillary electrophoresis","volume":"29","author":"Sagrado","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/elps.201600375","article-title":"Affinity capillary electrophoresis and fluorescence spectroscopy for studying enantioselective interactions between omeprazole enantiomer and human serum albumin","volume":"38","author":"Xu","year":"2017","journal-title":"Electrophoresis"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/jssc.202000372","article-title":"Investigation of the enantioselective interaction between selected drug enantiomers and human serum albumin by mobility shift-affinity capillary electrophoresis","volume":"43","author":"Ratih","year":"2020","journal-title":"J. Sep. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/bmc.3248","article-title":"Characterization of interactions between methoxatin disodium salt and human serum albumin by pressure-assisted capillary electrophoresis\/frontal analysis and circular dichroism spectroscopy","volume":"29","author":"Zhao","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpba.2015.06.022","article-title":"Application of capillary electrophoresis-frontal analysis for comparative evaluation of the binding interaction of captopril with human serum albumin in the absence and presence of hydrochlorothiazide","volume":"115","author":"Liu","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/elps.201600529","article-title":"Comparison of three methods for analyzing loureirin B and human serum albumin interaction using capillary electrophoresis","volume":"38","author":"Zhang","year":"2017","journal-title":"Electrophoresis"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1002\/jssc.202000594","article-title":"Applicability of capillary electrophoresis-frontal analysis for displacement studies: Effect of several drugs on l-tryptophan and lidocaine binding to human serum albumin","volume":"43","author":"Glatz","year":"2020","journal-title":"J. Sep. Sci."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/elps.200600742","article-title":"Evaluation of enantioselective binding of antihistamines to human serum albumin by ACE","volume":"28","author":"Sagrado","year":"2007","journal-title":"Electrophoresis"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.chroma.2011.03.025","article-title":"On the zopiclone enantioselective binding to human albumin and plasma proteins. An electrokinetic chromatography approach","volume":"1218","author":"Sagrado","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/bmc.2704","article-title":"Electrokinetic chromatographic estimation of the enantioselective binding of nomifensine to human serum albumin and total plasma proteins","volume":"26","author":"Sagrado","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Fernandes, C., Palmeira, A., Ramos, I.I., Carneiro, C., Afonso, C., Tiritan, M.E., Cidade, H., Pinto, P.C.A.G., Saraiva, M.L.M.F.S., and Reis, R. (2017). Chiral derivatives of xanthones: Investigation of the effect of enantioselectivity on inhibition of cyclooxygenases (COX-1 and COX-2) and binding interaction with human serum albumin. Pharmaceuticals, 10.","DOI":"10.3390\/ph10020050"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: A powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput.-Aided Drug Des."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/prot.10115","article-title":"Principles of docking: An overview of search algorithms and a guide to scoring functions","volume":"47","author":"Halperin","year":"2002","journal-title":"Proteins"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcc.21276","article-title":"Protein-protein docking dealing with the unknown","volume":"31","author":"Moreira","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Phyo, Y.Z., Cravo, S., Palmeira, A., Tiritan, M.E., Kijjoa, A., Pinto, M.M.M., and Fernandes, C. (2018). Enantiomeric Resolution and Docking Studies of Chiral Xanthonic Derivatives on Chirobiotic Columns. Molecules, 23.","DOI":"10.3390\/molecules23010142"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/chir.23297","article-title":"Chiral derivatives of xanthones and benzophenones: Synthesis, enantioseparation, molecular docking, and tumor cell growth inhibition studies","volume":"33","author":"Phyo","year":"2021","journal-title":"Chirality"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e2877","DOI":"10.1002\/jmr.2877","article-title":"Binding of direct oral anticoagulants to the FA1 site of human serum albumin","volume":"34","author":"Pasquadibisceglie","year":"2021","journal-title":"J. Mol. Recogn."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Ali, M.S., Muthukumaran, J., Jain, M., Al-Lohedan, H.A., Farah, M.A., and Alsowilem, O.I. (2021). Experimental and computational investigation on the binding of anticancer drug gemcitabine with bovine serum albumin. J. Biomol. Struct. Dyn., 1\u201314.","DOI":"10.1080\/07391102.2021.1924270"},{"key":"ref_171","first-page":"729","article-title":"Spectroscopic and molecular docking studies for characterizing binding mechanism and conformational changes of human serum albumin upon interaction with Telmisartan","volume":"28","author":"Bratty","year":"2020","journal-title":"Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"131278","DOI":"10.1016\/j.molstruc.2021.131278","article-title":"Synthesis and molecular interaction study of a diphenolic hidrazinyl-thiazole compound with strong antioxidant and antiradical activity with HSA","volume":"1244","author":"Mic","year":"2021","journal-title":"J. Mol. Struct."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"120543","DOI":"10.1016\/j.ica.2021.120543","article-title":"Synthesis, structure, DNA\/protein molecular docking and biological studies of hydrazone ligand derived Cu(II) and VO(IV) complexes","volume":"526","author":"Thirugnanasundar","year":"2021","journal-title":"Inorg. Chim. Acta"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.molstruc.2019.04.126","article-title":"HSA-interaction studies of uranyl complexes of alkyl substituted isothiosemicarbazone","volume":"1193","author":"Yasrebi","year":"2019","journal-title":"J. Mol. Struct."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"114618","DOI":"10.1016\/j.molliq.2020.114618","article-title":"Interaction of a hydrophilic molecule with bovine serum albumin: A combined multi-spectroscopic, microscopic and isothermal calorimetric study in the presence of graphene oxide","volume":"323","author":"Bapli","year":"2021","journal-title":"J. Mol. Liq."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Leek, H., and Andersson, S. (2017). Preparative scale resolution of enantiomers enables accelerated drug discovery and development. Molecules, 22.","DOI":"10.3390\/molecules22010158"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jchromb.2018.10.002","article-title":"Multi-milligram resolution and determination of absolute configuration of pentedrone and methylone enantiomers","volume":"110","author":"Silva","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/chir.22703","article-title":"Resolution, determination of enantiomeric purity and chiral recognition mechanism of new xanthone derivatives on (S,S)-Whelk-O1 stationary phase","volume":"29","author":"Carraro","year":"2017","journal-title":"Chirality"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11419-016-0324-y","article-title":"Chiral enantioresolution of cathinone derivatives present in \u201clegal highs\u201d, and enantioselectivity evaluation on cytotoxicity of 3,4-methylenedioxypyrovalerone (MDPV)","volume":"34","author":"Silva","year":"2016","journal-title":"Forensic Toxicol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.chroma.2012.07.058","article-title":"Resolution and determination of enantiomeric purity of new chiral derivatives of xanthones using polysaccharide-based stationary phases","volume":"1269","author":"Fernandes","year":"2012","journal-title":"J. Chromatogr. A"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.trac.2013.05.022","article-title":"Chiral separations in food analysis","volume":"52","author":"Rocco","year":"2013","journal-title":"TrAC-Trends Anal. Chem."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"115761","DOI":"10.1016\/j.trac.2019.115761","article-title":"Chiral analysis in food science","volume":"123","author":"Bueno","year":"2020","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Phyo, Y., Ribeiro, J., Fernandes, C., Kijjoa, A., and Pinto, M.M.M. (2018). Marine natural peptides: Determination of absolute configuration using liquid chromatography methods and evaluation of bioactivities. Molecules, 23.","DOI":"10.3390\/molecules23020306"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Zin, W.W.M., Buttachon, S., Dethoup, T., Fernandes, C., Cravo, S., Pinto, M.M.M., Gales, L., Pereira, J.A., Silva, A.M.S., and Sekeroglu, N. (2016). New cyclotetrapeptides and a new diketopiperzine derivative from the marine sponge-associated fungus Neosartorya glabra KUFA 0702. Mar. Drugs, 14.","DOI":"10.3390\/md14070136"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"116326","DOI":"10.1016\/j.trac.2021.116326","article-title":"Challenges and innovations in chiral drugs in an environmental and bioanalysis perspective","volume":"142","author":"Barreiro","year":"2021","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"115783","DOI":"10.1016\/j.trac.2019.115783","article-title":"Analysis of chiral drugs in environmental matrices: Current knowledge and trends in environmental, biodegradation and forensic fields","volume":"124","author":"Ribeiro","year":"2020","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Chmielewska, A., Konieczna, L., and Baczek, T. (2016). A Novel Two-Step Liquid-Liquid Extraction Procedure Combined with Stationary Phase Immobilized Human Serum Albumin for the Chiral Separation of Cetirizine Enantiomers along with M and P Parabens. Molecules, 21.","DOI":"10.3390\/molecules21121654"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ejps.2009.09.011","article-title":"Enantioselective retention of \u03b2-blocking agents on human serum albumin and \u03b11-acid glycoprotein HPLC columns: Relationships with different scales of lipophilicity","volume":"38","author":"Barbato","year":"2009","journal-title":"Euro. J. Pharm. Sci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0021-9673(97)01232-6","article-title":"Capillary electrophoretic and high-performance liquid chromatographic studies of the enantioselective separation of \u03b11-adrenoreceptor antagonists","volume":"803","author":"Andrisano","year":"1998","journal-title":"J. Chromatogr. A"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02491614","article-title":"Modulation of Chromatographic Performances of HSA-Based HPLC Column by Reversible Binding of Lithocholic Acid","volume":"53","author":"Bertucci","year":"2001","journal-title":"Chromatographia"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0021-9673(00)00195-3","article-title":"Stereoselective binding of 2,3-substituted 3-hydroxypropionic acids on an immobilised human serum albumin chiral stationary phase: Stereochemical characterisation and quantitative structure-retention relationship study","volume":"876","author":"Andrisano","year":"2000","journal-title":"J. Chromatogr. A"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-4347(01)00493-5","article-title":"Stereoselective binding of 2-(4-biphenylyl)-3-substituted-3-hydroxy-propionic acids on an immobilised human serum albumin chiral stationary phase","volume":"768","author":"Andrisano","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-022X(02)00131-8","article-title":"Species-dependency in chiral-drug recognition of serum albumin studied by chromatographic methods","volume":"54","author":"Fitos","year":"2002","journal-title":"J. Biochem. Biophys. Methods"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1039\/C8NJ02309C","article-title":"A protein-based mixed selector chiral monolithic stationary phase in capillary electrochromatography","volume":"42","author":"Xu","year":"2018","journal-title":"New J. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.aca.2003.11.029","article-title":"Fast enantiomeric separation of propranolol by affinity capillary electrophoresis using human serum albumin as chiral selector: Application to quality control of pharmaceuticals","volume":"507","author":"Sagrado","year":"2004","journal-title":"Anal. Chim. Acta"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jpba.2005.03.028","article-title":"Chiral separation of oxprenolol by affinity electrokinetic chromatography-partial filling technique using human serum albumin as chiral selector","volume":"39","author":"Sagrado","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1002\/elps.200500304","article-title":"Multivariate optimization approach for chiral resolution of drugs using human serum albumin in affinity electrokinetic chromatography-partial filling technique","volume":"26","author":"Sagrado","year":"2005","journal-title":"Electrophoresis"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.aca.2006.09.036","article-title":"Enantioseparation of phenotiazines by affinity electrokinetic chromatography using human serum albumin as chiral selector: Application to enantiomeric quality control in pharmaceutical formulations","volume":"582","author":"Sagrado","year":"2007","journal-title":"Anal. Chim. Acta"}],"container-title":["Chemosensors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9040\/9\/11\/304\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:23:25Z","timestamp":1760167405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9040\/9\/11\/304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":199,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["chemosensors9110304"],"URL":"https:\/\/doi.org\/10.3390\/chemosensors9110304","relation":{},"ISSN":["2227-9040"],"issn-type":[{"value":"2227-9040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]}}}